Gut microbiota and intestinal epithelial ecosystem

The gut microbiota and intestinal epithelial ecosystem is a complex, multi-component biological interface that maintains host homeostasis through a symbiotic relationship between trillions of microorganisms and the intestinal mucosal barrier (NIH, 2023). This ecosystem serves as a primary site for nutrient absorption, metabolic processing, and immune system education, while simultaneously acting as a physical and biochemical shield against pathogenic invasion (Nature Reviews Gastroenterology & Hepatology, 2021). The epithelial layer, composed of specialized cells like enterocytes and goblet cells, is regulated by microbial signals, including short-chain fatty acids (SCFAs) that provide energy and promote barrier integrity (PubMed, 2022). Dysregulation of this system, characterized by microbial dysbiosis and increased epithelial permeability, is a hallmark of inflammatory bowel diseases, metabolic disorders, and systemic inflammation (StatPearls, 2023). Therapeutic strategies targeting this ecosystem range from direct microbial replacement via fecal microbiota transplantation to pharmacological modulation of the mucosal immune response and barrier function. Understanding the intricate crosstalk within this ecosystem is vital for developing targeted therapies for gastrointestinal and extra-intestinal diseases (Frontiers in Immunology, 2022).

Other names

Gut-microbiota-epithelial axisIntestinal mucosal barrierGut microbiome-host interfaceIntestinal ecosystemIntestinal mucosal ecosystem

Mechanisms of action for therapies targeting this ecosystem include the modulation of microbial populations to restore diversity, the reinforcement of epithelial tight junctions (e.g., via GLP-2 analogues), the neutralization of pro-inflammatory cytokines like TNF-alpha, and the induction of regulatory T-cells through microbial metabolites such as butyrate (PubMed, 2022; Nature Reviews, 2021).